Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2210713 | 0.86 | CYP1A2 (0.32) | CYP1A2 | |
| SCHEMBL10964692 | 0.84 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL1617609 | 0.81 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL117857 | 0.80 | CYP1A2 (0.36) | CYP1A2 | |
| SCHEMBL583686 | 0.78 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL3409194 | 0.78 | CYP1A2 (0.34) | CYP1A2 | |
| SCHEMBL16418243 | 0.77 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL2357386 | 0.75 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL3722471 | 0.75 | CYP1A2 (0.47) | CYP1A2 | |
| SCHEMBL1617534 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | L'OREAL (FR) | 2026-02-05 | — | — | US | claimed |
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | L'OREAL (FR) | 2026-01-01 | — | — | US | claimed |
| US-20250154123-A1 | COOLING COMPOUNDS AND COMPOSITIONS | V MANE FILS (FR) | 2025-05-15 | — | — | US | claimed |
| EP-4460283-A1 | COOLING COMPOUNDS AND COMPOSITIONS | V. Mane Fils (FR) | 2024-11-13 | — | — | EP | claimed |
| EP-4442241-A2 | RETINOL REPLACEMENT IN SKIN TREATMENT | Symrise AG (DE) | 2024-10-09 | — | — | EP | claimed |
| EP-3773445-B1 | RETINOL REPLACEMENT IN SKIN TREATMENT | SYMRISE AG (DE) | 2024-07-24 | — | — | EP | claimed |
| CN-117481998-A | Retinol substitutes in skin treatment | 西姆莱斯有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-117202794-A | Spice composition and food and drink | 高砂香料工业株式会社 | 2023-12-08 | — | — | CN | claimed |
| WO-2023131667-A1 | COOLING COMPOUNDS AND COMPOSITIONS | V. MANE FILS (FR) | 2023-07-13 | — | — | WO | claimed |
| WO-2022224708-A1 | FRAGRANCE COMPOSITION AND FOOD AND BEVERAGE | 高砂香料工業株式会社 | 2022-10-27 | — | — | WO | claimed |
| EP-0695509-B1 | Liquid l-n-menthol composition and process for its preparation | TAKASAGO PERFUMERY CO LTD (JP) | 2001-10-24 | — | — | EP | claimed |
| EP-0847268-B1 | REFRESHING COMPOSITIONS | MANE V FILS SA (FR) | 2001-09-12 | — | — | EP | claimed |
| US-6121315-A | MIXTURE CONTAINING MENTHYL SUCCINATE COOLANT | WARNER-LAMBERT COMPANY (US) | 2000-09-19 | — | — | US | claimed |
| US-5843466-A | Coolant compositions | V. MANE FILS S.A. (FR) | 1998-12-01 | — | — | US | claimed |
| EP-0847268-A1 | REFRESHING COMPOSITIONS | V. Mane Fils S.A. (FR) | 1998-06-17 | — | — | EP | claimed |
| WO-1998011867-A1 | ORAL COMPOSITIONS CONTAINING A ZINC COMPOUND | WARNER-LAMBERT COMPANY (US) | 1998-03-26 | — | — | WO | claimed |
| US-5725865-A | MONOMENTHYL SUCCINATE OR SALTS | V. MANE FILS S.A. (FR) | 1998-03-10 | — | — | US | claimed |
| US-5663460-A | CONTAINS ISOPULEGOL PARTLY REPLACED BY MENTHOXYPROPANEDIOL; IMPROVED FEELING OF COOLNESS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1997-09-02 | — | — | US | claimed |
| WO-1997007771-A1 | REFRESHING COMPOSITIONS | V. MANE FILS S.A. (FR) | 1997-03-06 | — | — | WO | claimed |
| EP-0695509-A2 | Liquid l-n-menthol composition and process for its preparation | Takasago International Corporation (JP) | 1996-02-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000602-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION | TAS2R40, BRDT, APOB | CYP1A2 3274/4885 |
| US-20260034046-A1 | ANHYDROUS HAIR TREATMENT COMPOSITION COMPRISING CATIONIC SURFACTANT AND FATTY ALCOHOL | KRT18, DSG1, PRKDC | CYP1A2 3308/4885 |
| US-20250154123-A1 | COOLING COMPOUNDS AND COMPOSITIONS | CBR3, DECR1, DECR2 | CYP1A2 458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.